Insignis, HLK Pharmacin receive FDA IND clearance for phase I trial of IN-001 in anaphylaxis Oct. 30, 2020 No Comments
ASHG 2020: New inflammatory disease, and maybe, a new classification system Oct. 28, 2020 No Comments